In our laboratory, we have established various disease-relevant biological systems, in vitro, ex vivo, and in vivo, to evaluate the effects of plant extracts and/or phytocompounds by using animal disease models and to investigate potential medical applications. For example, we have established inflammatory cell-based in vivo and in vitro assay systems as well as animal models for inflammatory relative disorders, lung cancer, and liver cancer. The mid- and long-term plans for this research program include: 

1. Conduct bioactivity studies on various Taiwan-grown medicinal plants focusing on inhibition of inflammation, tumor growth and metastasis, enhancement of cancer therapeutic efficacy or amelioration of the associated adverse effects.